LifeScan announced today that it partnered with i-SENS to launch a continuous glucose monitoring (CGM) system.
Malvern, Pennsylvania–based LifeScan develops the OneTouch Bluetooth-connected blood glucose meter and mobile diabetes app. It aims to provide simplicity, accuracy and trust in diabetes management.
i-SENS, a global in vitro diagnostics company, researches, develops and produces products leveraging advanced biosensor and electrochemical technologies. It currently offers blood glucose monitoring devices in more than 110 countries, including Korea, the U.S. and European countries.
Together, the companies plan to collaborate to launch the CGM system under the OneTouch Vita brand. They plan to launch the CGM products in Germany, Ireland, Portugal and Belgium by early 2027. Then, they expect to move into additional markets over time.
LifeScan said the announcement reflects its long-term commitment to bring new innovations to market. It expects the deal with i-SENS to bring together the trusted OneTouch brand and global distribution network with advanced technology and manufacturing capabilities. No changes will come to the rest of the OneTouch portfolio in connection with the arrangement.
This news comes at an interesting time for LifeScan, which eliminated most of its debt when it emerged from Chapter 11 in December 2025. The company’s CEO also announced her retirement after more than 15 years at LifeScan last month.
LifeScan and i-SENS did not provide any further details on the future CGM, such as form factor or wear time or other features. i-SENS currently offers the CareSens Air CGM device, distributed by Spirit Health and theALLYcgm distributed by AgaMatrix.
Commentary from LifeScan officials
James Rushing, LifeScan CFO, said:
“LifeScan has served the diabetes community for more than 40 years, and the addition of CGM is a significant milestone in the company’s evolution. This partnership allows us to bring a CGM solution to market under the OneTouch Vita brand with the quality, reliability, and customer experience people expect from LifeScan. We are excited to begin this launch in Europe and continue to expand access in the years to come.”
Michael Hooks, executive chair, said:
“Launching a CGM product line has been a long-term goal for LifeScan and we are proud to take this important step toward realizing that ambition. For years, we have seen the opportunity to incorporate CGM as a component of our offerings, and this partnership enables us to do so with a partner that shares our commitment to R&D excellence and product quality.”
